Cargando…
Design and Optimization of In Situ Gelling Mucoadhesive Eye Drops Containing Dexamethasone
Poor bioavailability of eye drops is a well-known issue, which can be improved by increasing the residence time on the eye surface and the penetration of the active pharmaceutical ingredient (API). This study aims to formulate in situ gelling mucoadhesive ophthalmic preparations. To increase the res...
Autores principales: | Szalai, Boglárka, Jójárt-Laczkovich, Orsolya, Kovács, Anita, Berkó, Szilvia, Balogh, György Tibor, Katona, Gábor, Budai-Szűcs, Mária |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498616/ https://www.ncbi.nlm.nih.gov/pubmed/36135271 http://dx.doi.org/10.3390/gels8090561 |
Ejemplares similares
-
Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application
por: Katona, Gábor, et al.
Publicado: (2021) -
Development and Characterization of Potential Ocular Mucoadhesive Nano Lipid Carriers Using Full Factorial Design
por: Kiss, Eszter L., et al.
Publicado: (2020) -
Formulation and Optimization of Sodium Alginate Polymer Film as a Buccal Mucoadhesive Drug Delivery System Containing Cetirizine Dihydrochloride
por: Pamlényi, Krisztián, et al.
Publicado: (2021) -
Optimization of a combined wet milling process in order to produce poly(vinyl alcohol) stabilized nanosuspension
por: Bartos, Csaba, et al.
Publicado: (2018) -
Design and Optimization of Nanostructured Lipid Carrier Containing Dexamethasone for Ophthalmic Use
por: L. Kiss, Eszter, et al.
Publicado: (2019)